SciLifeLab

Hands-on Workshop: Developing AI Agents in Life Sciences (Gothenburg)
2026-06-09 10:00 - 15:30 (Europe/Stockholm) | Korallrevet, Natrium, Medicinaregatan 7B, Gothenburg, 413 90, Sweden
We are delighted to invite you to join our upcoming workshop on “Developing AI Agents in Life Sciences”, organized by SciLifeLab Data Centre. AI agents are emerging as autonomous systems that orchestrate scientific workflows by interacting with digital tools and data sources. These have various implications for life science research. They can, for example, simplify complex analyses by automating data integration, run computational models, and coordinate experimental steps, making research pipelines more efficient and reproducible. In this on-site hands-on workshop held at Korallrevet, Natrium building (Medicinaregatan 7B) in Gothenburg, we will introduce and discuss AI Agents in life science, and engage in collaborative practical sessions. Welcome!

Date: 2026-06-09Time: 10.00-15.30 (coffee will be served from 9.30). Fika and lunch provided free of charge. Location: room Korallrevet, Natrium, Medicinaregatan 7B, Gothenburg. No remote participation.

Target audience: Researchers, PhD students, research infrastructure interested in learning more about and trying hands-on exercises with AI Agents. Participants with any university affiliation and industry researchers are welcome. Basic Python programming skills are required; previous experience working with Jupyter notebooks would be helpful. Participants must bring their own laptop.

Registration: We expect many to be interested in attending this event. After we reach max capacity, we will open a waitlist. If you cannot join, please cancel your registration as soon as possible to make your spot available for someone else. Please add dietary restrictions to your registration. Please register by June 5th at 24.00.

Register for the workshop

Speakers and Facilitators: Chris Long Huynh (PhD candidate, Uppsala University), and Mahbub Ul Alam and Johan Alfredéen (Data Engineers (AI) at SciLifeLab Data Centre).

The workshop will feature a series of engaging presentations, interactive discussions, and collaborative sessions focusing on:

Introduction to AI agent technologies

Applications, opportunities and challenges of AI Agents in life science

Hands-on tutorials with reasoning models, LangChain and MCP servers

Discussions on the role of AI agents in shaping the future of life science

Agenda

09:30-10:00 Light breakfast and networking

10.00-10.15 Presentation session 1: Introduction: Exploring how AI agents can transform life sciences. Speaker: Johan Alfredéen.

10.15-10.30 Demonstration Session: AI agents in action. Facilitators: Mahbub Ul Alam.

10:30-12:00 Hands-on Session 1: Developing AI agents with LangChain & ReAct. Session Facilitators: Dinh Long Huynh, Mahbub Ul Alam.

12:00-13:00 Lunch and networking

13:00-13:30 Continuation of Hands-on Session 1: Developing AI agents with LangChain & ReAct.

13:30-15:00 Hands-on Session 2: AI agent collaboration with the Model Context Protocol (MCP). Session Facilitators: Mahbub Ul Alam, Johan Alfredéen, Dinh Long Huynh.

15:00-15:15 Presentation Session 2: Deploying AI Agents: Legal, Technical, and Practical Considerations. Speaker: Johan Alfredéen.

15:15-15:30 Concluding Session: Open Q&A

15:30 Fika and networking

Registration: Please add dietary restrictions to your registration. If you cannot join, please cancel your registration.

This event is a organised by SciLifeLab Data Centre. For questions please contact serve@scilifelab.se .

Super-Resolution Imaging of Mitochondria
2026-06-09 15:15 - 16:15 | Air&Fire, SciLifeLab Stockholm, Tomtebodavägen 23A, Solna, Sweden
Professor Stefan Jakobs, Georg-August-Universität Göttingen, Germany

Abstract

Mitochondria are essential for cellular function, yet their small size, dynamic behavior, and intricate architecture pose challenges for conventional light microscopy, which is limited by the diffraction barrier. Super-resolution methods such as Stimulated Emission Depletion (STED) microscopy overcome this limitation, enabling visualization of mitochondrial features which are blurred with conventional microscopy. In this talk, I will present how we use STED and complementary imaging approaches to investigate mitochondrial ultrastructure such as the folding of the mitochondrial inner membrane, mitochondrial proteins, mitochondrial DNA and mRNAs. Our work aims to uncover how the inner membrane develops and maintains its complex folds, and how this architecture relates to gene expression within the organelle. I will also discuss emerging automation strategies that streamline STED workflows, potentially opening the door to broader adoption in biomedical research and clinical diagnostics.

Super-Resolution Imaging of Mitochondria

Mitochondria are essential organelles whose small size, dynamic behavior, and intricate architecture challenge conventional light microscopy, which is fundamentally limited by diffraction. Super-resolution techniques such as Stimulated Emission Depletion (STED) microscopy overcome this barrier, enabling the visualization of mitochondrial structures that remain unresolved with standard imaging approaches.

In this talk, I will present our use of STED and complementary imaging approaches to examine mitochondrial ultrastructure, including inner membrane organization, mitochondrial proteins, mitochondrial DNA and mRNAs. Ultimately, our work seeks to understand how the highly folded inner membrane is established and maintained, and how its architecture influences gene expression within the organelle.

I will highlight recent advances in the automation of STED microscopy that enhance throughput, reproducibility, and ease of use, bringing STED super-resolution imaging closer to routine applications in biological research and clinical settings.

Biography

Professor Jakobs is a cell biologist working at the interface of biology and advanced imaging. His laboratory pioneered the use of diffraction-limited super-resolution microscopy for cell biology. More recently, they have automated these approaches to enable drug screening at unprecedented optical resolution and high throughput. He has published more than 130 manuscripts on this topic and has an h-index of 83 (according to Google Scholar). In addition to his affiliation with the University Medical Center Göttingen, he leads a research group at the MPI for Multidisciplinary Sciences and is head of the Göttingen Fraunhofer Site – Translational Neuroinflammation and Automated Microscopy. He holds an ERC Advanced Grant focusing on the analysis of mitochondrial ultrastructure using super-resolution microscopy and is spokesperson of the DFG-funded Research Unit FOR2848, which focuses on the application of advanced microscopic technologies to questions in cell biology.

Host: Ilaria Testa ilaria.testa@scilifelab.se

[The Svedberg seminar] - Tissue Regulatory T cells
2026-06-12 15:15 - 16:15 | BMC Room C8:305
Adrian Liston

ProfessorUniversity of Cambridge, UK

Bio

Adrian Liston is Professor of Pathology at the University of Cambridge and Equalities Fellow at St Catharine’s College. Prof Liston is highly published in immunology and neuroimmunology, in particular his work on regulatory T cells in the brain, and manipulating the population for therapeutic benefit. He has been awarded fellowship to the Academy of Medical Sciences, the Francqui Chair, the Eppendorf Prize, two Wellcome Trust awards and four ERC grants, among other honours. Beyond his research, Prof Liston is a prolific writer and workshop coordinator on the topics of navigating a science career and improving research culture. Finally, Prof Liston is also an extensive public communicator, including writing several illustrated books for children and designing educational computer games.

Tissue Regulatory T cells

Tregs have well-defined roles in limiting systemic immune responses, with additional functions for tissue-resident Tregs becoming increasingly apparent. These tissue-resident Tregs have diverse beneficial roles in tissue physiology, such as aiding homeostasis and promoting tissue repair and regeneration. In this talk Prof Liston will discuss the molecular features and cellular kinetics that drive tissue residency for Tregs, and the potential for clinical translation.

Host: Kailash Singh kailash.singh@mcb.uu.se

Uppsala Antibiotic Days 2026
2026-06-15 08:00 - 2026-06-16 17:00 | Biskopsgatan 3, 753 10 Uppsala, Biskopsgatan 3, Uppsala, 753 10, Sweden
You can now sign up for two days of talks, discussions, and community-building in Uppsala on 15-16 June 2026. This conference is a welcoming space for students, early-career researchers, and established experts alike. Focusing on collaboration and exchange across disciplines, the broad program will cover drug discovery, diagnostics, social sciences, infection control, and antibiotic use effects, among other topics. Participants are encouraged to submit abstracts for presentation! Location: Uppsala University Main Building, Biskopsgatan 3, 753 10 Uppsala, Sweden

In collaboration withSciLifeLab – Pandemic Laboratory PreparednessUppsala Antibiotic CenterPLATINEAENABLE-2

Confirmed Keynote Speakers

Ursula Theuretzbacher – expert in antibacterial drug-discovery & development strategies.

Rafael Cantón – clinical microbiology specialist.

Anne Kveim Lie – professor in global health & history of medicine.

Rob Warren – TB genomics researcher.

Rena Conti – health economics and pharmaceutical markets expert.

Joakim Larsson – environmental pharmacology & antibiotic-resistance in the environment.

Evelina Tacconelli – infectious-diseases researcher and pandemic-preparedness lead.

Scott Weese – public health & zoonoses professor.

Martha Clokie – phage research specialist.

Tobias Spielmann – Malaria researcher.

Read more and Register

Striving for Open Science Compliance in Sweden: Achieved Goals and Remaining Challenges
2026-06-15 11:00 - 12:00 | https://uu-se.zoom.us/j/65432842101?from=addon
DescriptionOpen Science is high on the Swedish research agenda, but are we actually delivering increased openness? Join this seminar to find out what the latest data reveals about where progress is being made, where it is stalling, and what the findings mean for your own work with open access, open data, and research visibility.

Open Science has become increasingly embedded in Swedish research policy. Despite ambitious national targets, Sweden did not achieve full open access to academic publications by 2021, and open research data is unlikely to reach full implementation by 2026, highlighting a persistent gap between policy ambitions and institutional practice. This presentation examines the implementation of Open Science in Swedish higher education institutions using longitudinal data from the SUHF Roadmap for Open Science surveys (2023–2025, as published in https://doi.org/10.7557/11.8391), including newly available 2026 results. It highlights areas where implementation has progressed most strongly, identifies areas where development remains weak, and discusses the structural changes needed for Open Science to become fully embedded across Swedish academia.

Presenter: Ineke Luijten, (PhD), Scientific Training Officer at SciLifeLab & Analyst of the annual SUHF OS implementation survey

Recording: https://www.youtube.com/watch?v=7BDKxUjJ524

More information
This event is part of the SciLifeLab Open Science seminar series, an event series by the SciLifeLab Data Centre and NBIS joint Data Management team.The goal of the events in this seminar series is to provide interesting interactive seminars around topics related to Research Data Management and Open Science in general, and to foster discussions around best practices.

Research Data Management (RDM) concerns the organization, storage, preservation, and sharing of data that is collected and analyzed during a research project. Proper planning and management of research data will make project management easier and more efficient while projects are being performed. It also facilitates sharing and allows others to validate as well as reuse the data.Open Science is a set of principles and practices that aim to make scientific research from all fields accessible to everyone for the benefits of scientists and society as a whole. Open science is about making sure not only that scientific knowledge is accessible but also that the production of that knowledge itself is inclusive, equitable and sustainable.

The events are open to everyone working at or affiliated with a Swedish research institute or university. We welcome all researchers, educational professionals, staff, RDM professionals, and others with an interest in life sciences, from all university levels. The events are informal and inclusive, so feel welcome to join and participate in our interesting discussions!

The events will be recorded and published openly after the seminars on the SciLifeLab YouTube channel. The slides will be made available at our SciLifeLab Data Repository.More information about SciLifeLab Data Centre and NBIS joint Open Science seminar series: https://www.scilifelab.se/data/scilifelab-data-management-seminar-series/

If you have suggestions for topics or presentations, please contact us at data-management@scilifelab.seFor more information or inquiries, please contact us at data-management@scilifelab.se

Cryo-electron microscopy as a discovery tool in sperm biology
2026-06-16 11:00 - 12:00 | Air&Fire, SciLifeLab Stockholm, Tomtebodavägen 23A, Solna, Sweden
Speaker: Tzviya Zeev-Ben-Mordehai, Utrecht University

Abstract

Cryo-EM single-particle analysis (SPA) approaches typically entail overexpression and purification of the target complex. For that, prior knowledge of the composition of the complex of interest is required. In the highly specialised sperm cell, the molecular composition is often not known. During my talk, I will show how we expand the range of samples attainable for SPA towards more native samples, specifically towards complex macromolecular assemblies that cannot be reconstituted, and show how SPA is used as a discovery tool in sperm biology.

Biography

An expert in reproductive structural biology. Zeev-Ben-Mordehai received her PhD from the Weizmann Institute of Science in 2008. In 2015 she established her group in the Division of Structural Biology of Oxford University. Since 2017 her group is part of Bijvoet Centre for Biomolecular Research of Utrecht University. Her group developed the first cryo-ET workflow for mammalian sperm, enabling molecularresolution imaging of flagellar ultrastructure across species. Her landmark studies have revealed the multi-scale architecture of mammalian sperm flagella (EMBO J 2021), structural specialisations of the sperm tail (Cell 2023), structural diversity of axonemes across mammalian motile cilia (Nature 2025), and in-cell structures at the mitochondria– cytoskeleton interface in sperm (PNAS 2021). Zeev-Ben-Mordehai is a recipient of a Wellcome Trust and The Royal Society Sir Henry Dale Fellowship (2015), NWO START-UP (2018), ERC-consolidator grant (2023) and an NWO-Vici grant (2025).

Host; Luca Jovine luca.jovine@ki.se

ICP2026 - International Conference on Palaeogenomics
2026-06-23 08:00 - 2026-06-27 17:00 | Aula Magna, Frescativägen 6, Stockholm, 114 18 Stockholm, Sweden
The first edition of the International Conference on Palaeogenomics (ICP2026) will happen in Stockholm, June 23-26 2026.

Join us for four exciting days as we bring together leading researchers, emerging scholars, and professionals from around the world to explore the latest advances in palaeogenomics. Held in the heart of Stockholm, the conference offers a unique opportunity to exchange knowledge and foster collaboration with contributions in a broad range of topics within ancient DNA research.

Information and abstract submission

Everyone welcome!

Från genetisk data till behandling: hur bygger vi en jämlik cancervård i hela landet?
2026-06-24 09:30 - 10:15 | Birgers Gränd 9, Birgers Gränd 9, Visby, Sweden
Beskrivning av samhällsfrågan

Precisionsdiagnostik flyttar fokus från var cancern sitter i kroppen, till tumörens genetiska profil. Men avancerad testning kräver specialistkompetens och strukturer för tolkning av stora datamängder. Hur säkerställer vi jämlik tillgång till rätt testning och rätt behandling i hela landet?

Read more

Utökad information om evenemanget

Molecular Tumour Board (MTB) är en central funktion i modern cancervård där multidisciplinära expertteam tolkar komplex genetisk information för att kunna välja rätt behandling till rätt patient. Men tillgången till både avancerad genetisk testning och till expertis inom MTB varierar i landet. Detta riskerar att förstärka ojämlikheter i cancervården och försvåra implementeringen av precisionsmedicin i klinisk praxis. Hur säkerställer vi att alla patienter får tillgång till rätt diagnostik, rätt tolkning och rätt behandling – oavsett var de bor? Seminariet sätter fokus på det strategiska vägval Sverige står inför: • Hur ser vi till att MTB blir en nationell angelägenhet avpassad efter regionala behov? • Vilka investeringar krävs i infrastruktur, kompetens och datahantering? • Hur säkerställer vi att innovation omsätts i faktisk patientnytta – för alla, inte bara för vissa? Diskussionen samlar beslutsfattare, vårdgivare och experter för att identifiera konkreta vägar framåt.

Medverkande

Medverkande

Anders Edsjö, Överläkare, Sektionschef klinisk patologi, vice föreståndare GMS, Region Skåne, GMS

Janne Lehtiö, Professor, Karolinska Institutet, SciLifeLab

Edvard Abel, Centrumföreståndare, PI FOCU.SE-trial, Sahlgrenska CCC

Pernilla Grillner, Verksamhetschef Högspecialiserad vård Astrid Lindgrens Barnsjukhus samt forskare , Karolinska Universitetssjukhuset, Karolinska Institutet

Daniel Ågren, Personalised Healthcare Lead, Roche

Johanna Svensson, Verksamhetschef, RCC Väst

Richard Rosenquist Brandell, Professor, överläkare (moderator), GMS, Karolinska Institutet, Karolinska sjukhuset

Nicklas Sandström , Oppositionsregionråd, Region Västerbotten , M

Susanne Dieroff Hay, Förbundsordförande, Bröstcancerförbundet

Rachel de Basso, Regionråd , Region Jönköpings län, S

Jonas Claesson, Hälso- och sjukvårdsdirektör , Västra Götalandsregionen

Sverige kan ta ledarposition i införande av banbrytande teknologier och AI i hälso- och sjukvården
2026-06-24 11:00 - 11:45 | D-huset, Campus Gotland, Kaserngatan 1, Visby, Sweden
Ämne: Vård och Omsorg, Innovation

Arrangör: Uppsala universitet, SciLifeLab

Plats: Cramérgatan 3, Torget

Beskrivning av samhällsfrågan

Hur kan Sverige möta hälso- och sjukvårdens komplexa utmaningar och möjliggöra precisionsmedicin genom att kombinera patientdata, AI, teknologiutveckling och forskning?

Utökad information om evenemanget

Sverige har unika förutsättningar: världsledande universitetssjukhus, tillförlitliga hälsodata, SciLifeLabs nationella forskningsinfrastruktur, högkvalitativ forskning och avancerad teknologiutveckling vid universiteten. Att systematiskt koppla samman forskning vid universiteten, SciLifeLabs forskningsinfrastruktur och universitetssjukhus möjliggör snabbare införande av avancerad teknologi för klinisk nytta. Genom gemensamma enheter vid universitetssjukhusen kan utveckling och anpassning av avancerade teknologier göras inom molekylär analys, data-driven forskning och AI för att stärka den kliniska forskningen och brett genomslag av precisionsmedicin i Sverige. Långsiktig finansiering av dessa enheter och samverkan mellan hälso- och sjukvården, akademin, industrin och patienter är avgörande för att lyckas med detta ambitiösa men nödvändiga mål. Vi diskuterar varför dessa gemensamma strukturer behöver skapas och hur de kan utformas för att stärka Sveriges kliniknära forskning.

Read more

Medverkande

Lars Almroth, direktör för hälso- och sjukvård, Socialstyrelsen

Anders Edsjö, vice föreståndare för Genomic Medicine Sweden, Region Skåne

Christophe Pedroletti, sjukhusdirektör för Karolinska universitetssjukhuset

Boubou Hallberg, direktör för Sahlgrenska universitetssjukhuset, Sahlgrenska Universitetssjukhuset Christ

Helena Goike, Health Policy Director, AstraZeneca

Jenny Nyström, Dekan, Sahlgrenska akademin, Göteborgs universitet

Päivi Östling, Hälsodataexpert, Karolinska Institutet och SciLifeLab

DigitaltEuropa möjliggör satsningar på humandata för bättre hälsa, sjukvård, forskning, innovation
2026-06-24 13:00 - 14:00 | D-huset, Campus Gotland, Kaserngatan 1, Visby, Sweden
Beskrivning av samhällsfrågan

De stora europeiska digitala satsningarna inom biomedicin ger tillgång till miljontals DNA-sekvenser för forskning, sjukvård och innovation – 1+MG (One Million Genome Initiative), GDI (Genomic Data Infrastructure) och GoE (Genome of Europe).

Utökad information om evenemanget

Nu 2026 kommer en EDIC (European Digital Infrastructure Consortium) att bildas för att möjliggöra dessa satsningar. En Genom-EDIC är instrumentell för utveckling av precisionsmedicin med förbättrad hälso- och sjukvård samtidigt som den möjliggör avancerad forskning och förbättrad innovation. Sverige är ledande i flera av dessa projekt genom att bygga den digitala infrastrukturen. Vid seminariet kommer vi att presentera i) Projektet GDI (European Genomic Data Infrastructure) och dess möjligheter för precisionshälsa och precisionsmedicin. ii) Projektet GoE (Genome of Europe) som samlar in ”normal-DNA” som skall fungera som jämförelsematerial vid diagnostik. iii) Genom-EDIC som den legala enkonstruktion för 1+MG Därefter vidtar en paneldiskussion med presentatörerna och möjligheter för alla att ställa frågor så att vi får en öppen diskussion med tillfälle till fördjupning.

Read more

Medverkande

Bengt Persson, Professor i bioinformatik , Uppsala Univeristet, SciLifeLab, NBIS, GDI

Richard Rosenquist Brandell, Överläkare, professor, föreståndare GMS, Karolinska Institutet, Karolinska sjukhuset

Manólis Nymark, Jurist, GDI, GoE och GMS

Åsa Johansson, Professor, Uppsala Universitet, SciLifeLab, GMS

Prevention, precision och partnerskap för framtidens cancervård
2026-06-25 08:00 - 17:00 | Birgers Gränd 9, Birgers Gränd 9, Visby, Sweden
Beskrivning av samhällsfrågan

Hur går vi från politiska ambitioner till verklig förändring i cancervården? Cancer är en global samhällsutmaning. För att möta den måste vi skapa bättre förutsättningar för att implementera ny kunskap, nya metoder och interventioner. Vi behöver tänka nytt och anta ett helhetsperspektiv på hälsa.

Utökad information om evenemanget

Cancer Mission Day samlar ledande aktörer från vård, forskning, myndigheter, industri och civilsamhälle för att tillsammans utforska hur prevention, precisionsmedicin, hälsodata och nya arbetssätt kan stärka både patientnytta och Sveriges konkurrenskraft. Genom tvärsektoriella samtal och konkreta exempel visar dagen hur cancerstrategin kan omsättas i handling – från tidig upptäckt och datadriven innovation till jämlik uppföljning och livskvalitet. Dagen avslutas med lanseringen av SweCan, Sveriges Cancer Mission Hub, där oväntade möten blir drivkraften för nästa steg i systemförändringen.

Read more

Evenemangsinformation

Evenemangstyp: Träffpunkt

Evenemangs-ID: 8099

Språk: Svenska och Engelska

Förtäring: Ja

Arrangörsuppgifter

Kontaktperson: Ebba Hallersjö Hult, Ledare Testbed Sweden Precision Health Cancer, Stockholm School of Economics Institute for Research (SIR), ebba.hallersjo.hult@hhs.se

Jonas Vikman, VD, Victri Advice, jonas.vikman@victri.se

AI och hälsodata – går vi äntligen från vision till verklighet i cancervården?
2026-06-25 13:00 - 13:45 | Birgers Gränd 9, Birgers Gränd 9, Visby, Sweden
Beskrivning av samhällsfrågan

AI och avancerad dataanalys kan bidra till tidigare upptäckt, mer träffsäkra behandlingsbeslut och bättre uppföljning i cancervården. Men i dag hindrar fragmenterade IT-system, otydliga regelverk och begränsad datadelning utvecklingen. Hur skapar vi en mer datadriven cancervård?

Utökad information om evenemanget

Cancer är en av vår tids största folkhälsoutmaningar och antalet cancerfall väntas öka i takt med en åldrande befolkning. Samtidigt utvecklas nya diagnostiska metoder, behandlingar och datadrivna verktyg i snabb takt. För att dessa innovationer ska komma patienter till nytta behöver vården kunna använda hälsodata mer effektivt, säkert och strukturerat än i dag. Sverige har goda förutsättningar genom nationella register, hög digital mognad och stark forskning. Trots detta finns betydande hinder för hur hälsodata kan delas, analyseras och användas i klinisk verksamhet, kvalitetsuppföljning och forskning. Bristande interoperabilitet, otydliga regelverk och fragmenterade IT-system gör att potentialen i AI och avancerad dataanalys inte utnyttjas fullt ut. Seminariet diskuterar hur AI och bättre användning av hälsodata kan bidra till tidigare upptäckt, mer individanpassad diagnostik och bättre behandlingsbeslut – och hur Sverige kan dra nytta av initiativ som European Health Data Space.

Read more

Medverkande

Ninnie Borendal Wodlin, Vårddirektör , Region Östergötland

Päivi Östling, Docent, SciLifeLab

Karin Liljelund, Patientföreträdare, Lungcancerföreningen, Patientrådet FOCU.SE-trial, Patientrådet Karolinska

Ulrika Nyberg, Head of Strategic Partnerships, Mavatar

Lisa Kirsebom, Moderator

Fredrik Lindén, Seniorkonsult, CoCentric

Oväntade samarbeten – nyckeln till framtidens cancervård och innovation?
2026-06-25 17:00 - 17:45 | Birgers Gränd 9, Birgers Gränd 9, Visby, Sweden
Beskrivning av samhällsfrågan

Vad kan vi göra tillsammans som ingen aktör klarar ensam? Cancer kräver nya samarbeten över sektorer och gränser. Hur kan Sverige ta en ledande roll Europas samarbete och omsätta innovation till konkret nytta för patienter och samhälle?

Utökad information om evenemanget

Sverige har starka förutsättningar inom forskning, vård och innovation, men står inför utmaningar i att omsätta kunskap till jämlik och effektiv cancervård. Ökat samarbete mellan sektorer och bättre koppling mellan nationella och internationella initiativ är avgörande för att möta framtidens behov. SweCan är Sveriges nationella Cancer Mission Hub inom ramen för regeringens uppdrag och samlar aktörer från akademi, hälso- och sjukvård, näringsliv och civilsamhälle. Genom att möjliggöra nya samarbeten och stärka koordineringen kan Sverige ta en tydligare roll i EU:s Cancer Mission och bidra till global utveckling inom life science. Cancer Mission Day avslutas med detta pass där deltagare från olika sektorer möts för att knyta kontakter, utbyta idéer och inspireras till konkreta initiativ som kan stärka svensk cancervård, forskning och innovation.

Read more

Medverkande

Martin Jansson, projektledare, SweCan

Mef Nilbert, överläkare, professor, Lunds universitet, Sakkunnig, Socialstyrelsen

Emelie Antoni, Nordenchef AstraZeneca, Ordförande Lif

Carl Johan Sundberg, professor Karolinska Institutet, Inspektor Medicinska Föreningen

Mia Phillipson, professor, Co-director SciLifeLab

Monika Magnusson, VD, Apotek Hjärtat

Ulrika Årehed Kågström, generalsekreterare, Cancerfonden

Barbro Sjölander, ordförande, Nätverket mot gynekologisk cancer

Johanna Lidén, Director Nordic & Sweden Medical & Regulatory, AstraZeneca

Lena Thyrell, medicinskt ansvarig för prostatacancer, Bayer

Annica Löfgren, forskningssjuksköterska, Region Skåne

Lars Olof Twetman, patientföreträdare, Prostatacancerförbundet

Eva Jolly, enhetschef, Karolinska Comprehensive Cancer Centre

Rickard Bracken, generalsekreterare, Mind

Eric Lundberg , VD, ICA Sverige

Niclas Wiklund, ICA-handlare, ICA Kometen Visby

Saranda Bajraktari, projektledare, Region Gotland

Jonas Vikman (moderator), VD, Victri Advice

From Folding to Function: How Trafficking Receptors Shape Membrane Protein Biogenesis
2026-08-14 14:00 - 15:00 | Air&Fire, SciLifeLab Stockholm, Tomtebodavägen 23A, Solna, Sweden
From Folding to Function: How Trafficking Receptors Shape Membrane Protein Biogenesis.Speaker: Prof. Simion Newstead from Oxford University

Membrane proteins perform essential cellular functions, but before they reach their final destination, they must fold correctly and pass stringent quality control in the endoplasmic reticulum (ER). How cells coordinate membrane protein folding with selective export from the ER remains poorly understood. In this seminar, I will discuss recent structural and mechanistic insights into the role of trafficking receptors in membrane protein biogenesis. Using cryo-electron microscopy alongside biochemical and cell-biological approaches, we show how cornichon trafficking receptors recognise membrane-protein cargoes, remodel the surrounding membrane, and recruit the COPII machinery to drive ER export. These studies reveal trafficking receptors as active regulators of membrane protein maturation and provide a structural framework for understanding how membrane proteins are assembled and trafficked within the cell.

4th BioSyst.EU Meeting 2026
2026-08-17 08:00 - 2026-08-19 17:00 | Ekonomikum, Kyrkogårdsgatan 10, 753 12, Uppsala
The 4th BioSyst EU meeting is taking place in Uppsala Sweden, 17th – 19th August 2026, and will be organised by the Swedish Systematics Association. The 3-day conference celebrates European systematics and biodiversity research at its origin. An excursion directly after the conference rounds off the program with keynotes and symposia.

The Conference is supported by the KAW initiative DDLS Evolution and Biodiversity research area. Contact DDLS Fellow Tobias Andermann and the DDLS Expert Group.

This conference will bring the European Biodiversity and Systematics community together at its Linnaean origin in Uppsala.

Keynote speakers

There will be three main keynote speakers with internationally leading research profiles: Sandra Knapp, Fredrik Ronquist and Paul Hebert. The latter is the father of DNA barcoding, coming all the way from Canada. The journal Systematics and Biodiversity will also publish a special collection of articles arising from the conference!

Program

During the conference, there will be the following symposia:

Trait Evolution, Lineage Diversification and Historical Biogeography in a Big Data era. Confirmed speaker: Isabel Sanmartín, Madrid.

Evolution in Deep Time: Fossils, Phylogenies, and Reconstructing the History of Life

AI and Automated Species Identification: Assets and Drawbacks

Advances in Museomics for Biosystematics and Taxonomy

Are biodiversity and ecosystems the same thing?

Natural History Collections and their actors

Taxonomic treatments and revisions and their accessibility in biodiversity databases

Data-driven research in evolution and biodiversity

Environmental DNA for species discovery and biodiversity inventory

Speciation, Adaptation and Phylogeography: Microevolutionary Processes Shaping Biodiversity

Open session

Early bird before May 31

Registration is open and it costs only 1 500 SEK for students registering before 31 May (BSc, MSc and PhD students). For everyone else the early-bird price is 2 500 SEK.

Early-career Day

There will be an early-career event the day before, free of charge – we have two international speakers this time, Seraina Klopfstein coming from Switzerland and Pablo Muñoz-Rodríguez coming from Spain. The early career event will be followed by some mingling and discussions, and dinner/beers. So don’t miss out!

Important dates!

Abstract submission ends 31st May 2026Early bird registration ends 31st May 2026Registration ends 17th July 2026

More information and Registration

Registration and event website: https://www.trippus.net/BioSyst2026

About BioSyst EU: https://biosyst.eu/

Olink Reveal: From Biomarkers to Biological Insight
2026-08-20 09:10 - 12:00 | Birgit Thilander Lecture Hall, Academicum, Medicinaregatan 3, Gothenburg
Join this morning seminar to learn how cutting-edge proteomics is accelerating biomedical research. The programme features presentations from Olink Proteomics, SciLifeLab Clinical Genomics Gothenburg, and researchers from the University of Gothenburg, highlighting applications of proteomics in human biology, machine learning, and precision medicine. In addition, representatives from the Proteomics Core Facility will be available to provide further research support.

Welcome, we hope to see you there! Olink Proteomics and Clinical Genomics Gothenburg

Registration

Agenda

09:10 – 09:15 | Welcome and introduction – Alejandro Muñoz PhD, BusinessDevelopment Manager, Olink Proteomics09:15 – 09:25 | Clinical Genomics Gothenburg, from sample to data – Catarina Mörck PhD, Service Coordinator SciLifeLab, sequencing unit, Sahlgrenska University Hospital09:25 – 10:00 | Accelerating Discovery with Olink Proteomics – Léocadie Henry PhD, Field Application Scientist, Olink Proteomics10:00 – 10:30 | Using machine learning for proteomics studies under highdimensionality – Saman Hosseini Ashtiani PhD, Postdoctor, Department of Clinical Neuroscience, University of Gothenburg10:30-11:00 | Fika and mingle11:00 – 11:30 | Blood Proteomics Profiling Reveals Dynamic Programs inCardiometabolic Disease – Muhammad Arif PhD, Associate Senior Lecturer. Department of Molecular and Clinical Medicine, University of Gothenburg11:30 – 12:00 | Olink Reveal in Plasma Identifies Patterns of Organ Involvement in Systemic Sclerosis – Yuan Zhang PhD, Researcher in Department of Rheumatology and Inflammation Research, University of Gothenburg

“The times they are a-changin”*: from transparency, to safety and scientific integrity, how is the race to AGI changing our scientific values?
2026-08-21 10:00 - 11:00 | Online event via Zoom
Heidi Howard

NBIS and SciLifeLab Data Centre arrange an open SciLifeLab AI Seminar Series aimed at knowledge-sharing about Artificial Intelligence and applications in the Life Science community. The seminar series is open to everyone. The seminar is run over Zoom on the third Friday of the month during academic terms, typically between 10 and 11 am, with approx. 45 min presentation and 15 min discussion.

When: August 21, 10:00-11:00

Where: Zoom http://meet.nbis.se/ainw

Speaker: Heidi HowardSenior Researcher, Industrial Biotechnology, Chalmers and ELSI lead at Scilifelab and DDLS

Abstract

The general question I am currently working on is: where do values like transparency, accountability, scientific integrity, replicability of science, respect for copyright, respect for privacy, and respect for the planet fit into the current rush to develop Artificial General Intelligence?

It does not take graduate work in ethics to see that in the last four years since OpenAI launched GPT-3.5 and that a number of other big and not-so-big players have spent loads of money, time, and GPUs/CPUs on developing large language models (LLMs, some supposedly on their way to AGI), that these values are being eroded. Many (most?) of the decisions are being taken by a few companies holding an inordinate amount of power, and these shifts are potentially being normalised by expert and lay publics who may not know or feel they have any influence to push against the wave of change. Based on examples taken from past (public) work developing evaluations of large language models for bioweapons information risks and some of my current work on the public discourse around the benefits and risks of developing A(G)I, this presentation will address scientific and ethical details that are easily overlooked in the current A(G)I rush.

*song title by Dylan B/Zimmerman RA. The Times they are a-changin’, 1964,

To stay updated, you can join our email list by contacting ai-network@scilifelab.se.

Join Seminar

Lipid regulation of TRP channels: More than meets the eye
2026-08-25 15:15 - 16:15 | Gamma 2 Lunchroom, SciLifeLab, Tomtebodavägen 23, Solna, Sweden
For the fall’s first Spotlight seminar, we are happy to welcome Professor Ute Hellmich from the Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry (IOMC) at Friedrich-Schiller-Universität Jena

Abstract

Cells rely on membrane receptors to detect and integrate diverse environmental signals. Ligands such as small molecules, peptides or ions trigger conformational changes that regulate downstream signalling cascades. This classic, 3D-centric view is challenged by the finding that nearly half of the human proteome is predicted to be intrinsically disordered.

Many membrane receptors, including most Transient Receptor Potential (TRP) channels, contain large intrinsically disordered regions (IDRs) whose dynamic nature has severely hampered structural characterization. Therefore, the contribution of IDRs to signal sensing remains poorly understood and the structural dimensions of TRP channels are notoriously underestimated.

Here, using an integrated structural biology approach, we show that disordered channel regions contribute to multipartite signalling networks of plasma membrane and lysosomal TRP ion channels and play crucial roles in lipid-dependent functional regulation. This work thus provides a conceptual blueprint how complex membrane receptors are regulated by

Blueprint to Study the Entire Spatial Cellular Metabolic Landscape
2026-08-26 15:00 - 16:00
This month’s Mass Spectrometry Imaging webinar features Prof. Ramon Sun from the University of Florida College of Medicine, USA. He will present the development of an advanced multimodal imaging approach at nanoscale resolution, integrating techniques such as focused ion beam imaging, helium ion microscopy, transmission electron microscopy, scanning probe microscopy, and NanoSIMS. He will also showcase applications of this approach across a range of research areas.

🕒 Time: 15:00–16:00 (presentation and discussion)☕ Followed by: Informal discussion with the speaker, 16:00–16:30📍 Format: Zoom

Zoom link

Meeting ID: 695 7569 0089Passcode: [REDACTED]

About the speaker

Prof. Ramon C. Sun holds the Anne and Oscar Lackner Endowed Chair and directs the Center for Advanced Spatial Biomolecule Research (CASBR). He is also Associate Director of Innovation at the McKnight Brain Institute. His laboratory develops mass spectrometry imaging techniques to map the metabolome, lipidome, and glycome from a single tissue section, and uses machine learning to reconstruct tissue metabolism in three dimensions.

Speaker: Prof. Ramon C. Sun

His group has uncovered central roles for glycogen and protein hyper-glycosylation in Alzheimer’s disease, cancer, and other disorders. His work has been published in Nature Metabolism, Nature Communications, Cell, and other leading journals.

Upper panel: A workflow for spatial glycomics using FFPE human brain samples.Lower panel: Spatial glycomics images demonstrating the distribution and intensity of glycans in human brain samples across Braak stages in Alzheimer’s disease (lower panels). Spatial intensity increases correlate with disease severity.” (Adopted from Figure 1, Nat Metab 8, 1410–1425 (2026). https://doi.org/10.1038/s42255-026-01538-4)

[The Svedberg seminar] - Genome-scale screens to program new T cell states for next-generation immunotherapy
2026-08-31 15:15 - 16:15 | BMC Room C4:305 , Husargatan 3, Uppsala, 752 37, Sweden
Neville Sanjana

Professor New York University, USA

Bio

Neville Sanjana, PhD, is a Core Faculty Member at the New York Genome Center and Professor of Biology, Neuroscience and Physiology at New York University. Recent work from his lab identified synthetic cell programs to enhance cell and gene therapies and developed new methods to identify causal noncoding variants and their target genes at scale. Dr. Sanjana is a recipient of the Presidential Early Career Award for Engineers and Scientists, AAAS Wachtel Prize for Cancer Research, the NIH’s New Innovator Award, the Cancer Research Institute Technology Impact Award, the DARPA Young Faculty Award, the Kimmel Scholar Award, the MRA Young Investigator Award, and also is a Leichtung Family Investigator of the Brain and Behavior Foundation.

Genome-scale screens to program new T cell states for next-generation immunotherapy

The engineering of patient T-cells for adoptive cell therapies has revolutionized the treatment of several cancer types, but further improvements are needed to increase response and cure rates. T-cell–mediated anti-tumor immunity relies on potent cytotoxic effector function, whereas durable tumor clearance depends on stemness-driven long-term persistence. However, endogenous T-cell differentiation programs render these phenotypes mutually exclusive: Effector maturation physiologically depletes the stem-like reservoir. Chimeric antigen receptor (CAR) T cells, despite their impact on blood cancer treatment, remain bound by this intrinsic biological trade-off.

To identify new genetic programs for effective cell therapy, we overexpressed ~12,000 barcoded human open reading frames (ORFs) and measured their impact on proliferation of primary human CD4+ and CD8+ T-cells. When overexpressed, the top-ranked ORF, lymphotoxin beta receptor (LTBR), induced profound transcriptional and epigenomic remodelling, increasing T-cell effector functions, as well as resistance to exhaustion in chronic stimulation settings, via constitutive activation of the canonical NF-kB pathway.

Using this gene, we develop a novel CAR that decouples effector differentiation from the loss of stemness. Direct fusion of the intracellular domain of the T-cell proliferation driver LTBR to the CD3ζ tail induces a shared pro-inflammatory effector program in both CD4⁺ and CD8⁺ CAR T cells. In the CD4⁺ compartment, this effector differentiation is accompanied by an overlay of stemness-associated gene modules (TCF7 and LEF1), resulting in a superimposed state where pro-inflammatory and self-renewal programs coexist. This dual phenotype is dependent on the CAR configuration and is not recapitulated by LTBR co-expression. In CAR T cells engineered from diffuse large B-cell lymphoma (DLBCL) patients, the LTBR-fusion CAR sustains tumor suppression after several rounds of repetitive tumor challenge. This lineage-specific phenotype is consistent with clinical observations linking durable remissions to persistent, effector-competent CD4⁺ CAR T cells. Together, our CAR engineering approach overrides canonical T cell differentiation constraints to yield dysfunction-resistant therapies, elucidating the functional basis of lineage-specific CD4⁺ CAR T-cell responses.

Host: Sanja Vickovic sanja.vickovic@scilifelab.uu.se UU

Massively-parallel approaches to understand the human noncoding genome and transcriptome
2026-09-01 15:15 - 16:15 | Air&Fire, SciLifeLab Stockholm, Tomtebodavägen 23A, Solna, Sweden
Professor Neville Sanjana, NYU, United States

Abstract

Professor Sanjana will present recent work from his lab on two topics: variant-to-function challenges in noncoding genomics and the development of RNA-targeting CRISPR screens to pinpoint functional noncoding RNAs.

First, since most disease-associated GWAS variants map to noncoding regions, we combined ancestrally diverse biobanks, massively parallel CRISPR screens, and single-cell sequencing to identify 124 target genes across 91 blood trait loci — enabling large-scale characterization of human GWAS variants and mechanisms. This work is part of an ongoing collaboration with Prof. Tuuli Lappalainen (KTH and SciLifeLab).

Second, while thousands of long noncoding RNAs (lncRNAs) are transcribed, less than 1% have established roles. Using RNA-targeting CRISPR-Cas13 screens, we evaluated 5,500 lncRNAs across five cell lines and identified 788 essential lncRNAs. Most function independently of neighboring protein-coding genes and exhibit dynamic expression during development. Finally, their expression in primary tumors correlates with patient survival, highlighting their potential as clinical biomarkers and therapeutic targets.

Biography

Neville Sanjana, PhD, is a Core Faculty Member at the New York Genome Center and Professor of Biology, Neuroscience and Physiology at New York University. Recent work from his lab identified synthetic cell programs to enhance cell and gene therapies and developed new methods to identify causal noncoding variants and their target genes at scale. Dr. Sanjana is a recipient of the Presidential Early Career Award for Engineers and Scientists, AAAS Wachtel Prize for Cancer Research, the NIH’s New Innovator Award, the Cancer Research Institute Technology Impact Award, the DARPA Young Faculty Award, the Kimmel Scholar Award, the MRA Young Investigator Award, and also is a Leichtung Family Investigator of the Brain and Behavior Foundation.

From Messy Data to Clean Datasets: A Practical Introduction to OpenRefine
2026-09-08 11:00 - 12:00 | https://uu-se.zoom.us/j/66405928096
Messy and inconsistent data is a common challenge in research, often making it difficult to analyse, share, and reuse data effectively. Improving data quality is therefore a key step towards more reproducible research and better alignment with Open Science and FAIR principles.

In this session, we will introduce OpenRefine, an open-source tool designed to help researchers explore, clean, and transform messy tabular data. OpenRefine is particularly useful for working with spreadsheets and datasets containing inconsistencies such as duplicate entries, varying formats, or typographical errors.

We will begin with a short introduction to the types of data challenges OpenRefine can address, followed by a live demonstration showing how to work with real data. The demo will highlight key features and how these can be used to efficiently identify and resolve inconsistencies in datasets.

The session will conclude with an open Q&A, providing an opportunity to ask questions and discuss how these approaches can be applied in your own research context.

No prior experience with OpenRefine is required.

Elisavet Torstensson, SciLifeLab, Data Steward NBIS- FEGA Sweden Helpdesk Team- Elixir Sweden

More information
This event is part of the SciLifeLab Open Science seminar series, an event series by the SciLifeLab Data Centre and NBIS joint Data Management team.The goal of the events in this seminar series is to provide interesting interactive seminars around topics related to Research Data Management and Open Science in general, and to foster discussions around best practices.

Research Data Management (RDM) concerns the organization, storage, preservation, and sharing of data that is collected and analyzed during a research project. Proper planning and management of research data will make project management easier and more efficient while projects are being performed. It also facilitates sharing and allows others to validate as well as reuse the data.Open Science is a set of principles and practices that aim to make scientific research from all fields accessible to everyone for the benefits of scientists and society as a whole. Open science is about making sure not only that scientific knowledge is accessible but also that the production of that knowledge itself is inclusive, equitable and sustainable.

The events are open to everyone working at or affiliated with a Swedish research institute or university. We welcome all researchers, educational professionals, staff, RDM professionals, and others with an interest in life sciences, from all university levels. The events are informal and inclusive, so feel welcome to join and participate in our interesting discussions!

The events will be recorded and published openly after the seminars on the SciLifeLab YouTube channel. The slides will be made available at our SciLifeLab Data Repository.More information about SciLifeLab Data Centre and NBIS joint Open Science seminar series: https://www.scilifelab.se/data/scilifelab-data-management-seminar-series/

If you have suggestions for topics or presentations, please contact us at data-management@scilifelab.seFor more information or inquiries, please contact us at data-management@scilifelab.se

Webinar on Calls for New Projects in Chemical Biology and Drug Discovery
2026-09-08 11:00 - 12:00
The Chemical Biology Consortium Sweden (CBCS) and the Drug Discovery and Development (DDD) Platform at SciLifeLab invite researchers to submit proposals for new collaborative projects.Chemical biology projectsThe Chemical Biology unit (CBCS) welcomes projects involving:

Assay development for small-molecule screening

Phenotypic and target-based screening and in silico – virtual screening support

Enabling chemistry, including medicinal and computational chemistry

Drug profiling projects in advanced cell models (patient derived material and 3D cultures)

Many of the projects supported by CBCS involve phenotypic screening addressing basic research, disease biology but also projects outside human health. Further information is available at www.cbcs.se.Drug discovery & Development projectsThe DDD Platform invites proposals addressing a clearly defined unmet medical need and offering a credible route toward commercialisation. Projects involving any therapeutic modality that can be developed in collaboration with DDD are welcome, including:

Small molecules

Antibodies

Oligonucleotides

Emerging therapeutic modalities

This year’s call introduces a joint opportunity supported by CBCS, DDD and MAX IV.

New opportunity: Enabling Drug Discovery (EDD)Through the Enabling Drug Discovery (EDD) initiative, the combined capabilities of SciLifeLab DDD, CBCS and MAX IV offer academic researchers an integrated workflow for early-stage target based drug discovery. The support includes expert support on assay design, technology transfer and hit verification, together with access to complementary discovery approaches such as:

AI-assisted in silico screening for small molecules

High-throughput screening (HTS) for small molecules

Selection for small molecule binders from DNA-encoded compound libraries (DEL)

Fragment screening (crystallographic screening at MAX IV and by NMR at CBCS)

Selection for human antibody fragments from Phage display libraries

Design and synthesis of custom-made oligonucleotide libraries

Principal investigators who successfully co-develop and validate suitable assays will be offered the opportunity to screen for potential therapeutic candidates. The resulting hits and data can provide a strong foundation for further scientific investigation and subsequent applications to SciLifeLab’s CBCS and Drug Discovery and Development (DDD) platforms.Some users and projects are at the intersection between chemical biology and drug discovery.This webinar aims to guide users to the call that best suits the needs of their project.

Register

PLP Network Meeting 2026
2026-09-09 09:00 - 2026-09-10 13:30 | Nova Park, Gredelbyvägen 138, 741 71, Knivsta
The Pandemic Laboratory Preparedness (PLP) Network Meeting brings our community together to strengthen connections across the PLP network, spark new collaborations, and identify exciting opportunities for future development and impact.

Through inspiring invited talks, an engaging poster session, interactive group discussions, and plenty of social activities, the meeting will create a dynamic forum for exchanging ideas, sharing expertise, and building the partnerships that will shape future pandemic preparedness efforts

Invitation only

Contact. Alice Sollazzo, alice.sollazzo@scilifelab.uu.se

Program

Program PLP Network Meeting 2026Download

Poster List

Poster List – PLP Retreat 2026Download

Busses

To Nova Park – September 9FromDepartureUppsala (BMC), Husargatan 3, entrance C1109:00Stockholm, Cityterminalen (via Campus Solna)08:30Arlanda, T409:00From Nova Park – September 10DepartureToUppsala (BMC), Husargatan 3, entrance C1113:30Stockholm, Cityterminalen (via Campus Solna)13:30Arlanda, T413:30

Scientific Committee:

Staffan Svärd, UU

Jessica Alm, KI

Claudia Fredolini, KTH

Tobias Allander, KI

Mattias Forsell, UmU

Mahmoud Naguib, UU

Sleeping sickness on the path to disease elimination: The tale of two drugs
2026-09-10 14:30 - 15:00 | Gamma 2 Lunchroom, SciLifeLab, Tomtebodavägen 23, Solna, Sweden
Welcome to a seminar with Peter Sjö in the Chemical Biology Seminar Series.

Peter Sjö, Head Drug Discovery Projects at Drugs for Neglected Diseases initiative (DNDi).

Synthetic DNA for in-product data storage and cryptography
2026-09-16 15:00 - 16:00 | Air&Fire, SciLifeLab Stockholm, Tomtebodavägen 23A, Solna, Sweden
Robert Grass, Functional Materials Laboratory, Department of Chemistry and Applied Biosciences, ETH Zurich

Short abstract:DNA data storage has emerged as technical solution to store digital data at very high data densities. In addition, data in DNA can be rendered stable for long time horizons by the application of nanotechnological preservation technologies, using both sol-gel as well as metal organic framework approaches. In practical terms, DNA data storage offers data stability for hundreds of years and data densities exceeding 40 exabytes per gram. While this brings opportunities in the field of cloud storage applications, our research focuses more on ideas in combining DNA data storage with materials. It is our ultimate goal to give materials a digital identity. We have so far investigated applications in 3d printing, pharmaceuticals, construction materials and polymer recycling. I will not only be discussing the technical advantages and limitations, but will also touch on practicability and technology commercialisation aspects. I will conclude the presentation on a second class of lesser-known digital technologies, which uses physical and chemical randomness to create unclonable functions, and allows a discussion of physical randomness in the context of digital cryptography.

Campus Solna Science Talks 2026
2026-09-17 08:30 - 17:00 | Life City, Solnavägen 3H, Stockholm, 113 64
Warmly welcome to the seventh Campus Solna Science Talk – a meeting for everyone in the community to learn more about ongoing research and activities at SciLifeLab’s Campus Solna, which aims to bring the community together, inspire exchange and new collaborations.

Research presentations will be given by group leaders and junior researchers (selected with consideration for balance in topics, presenters’ career stages, and affiliations) as part of four plenary sessions that will be mixed with panel discussions. During breaks and lunch there will be ample time for networking and poster sessions.

We invite all Campus Solna research groups to be represented with at least 1 poster (and maximum 3). Furthermore, we want to encourage all infrastructure units, support functions (IT, OO, Site support) and committees (DEI, Public Engagement, CSI and the PhD&Postdoc Council) to partake with posters!

Seats are limited, register today to secure your spot!

Registration

Program
8.45Welcoming and opening of symposiumHjalmar Brismar, Director Campus Solna9.00Session I: Big Data, Reference-Free Methods & Spatial AtlasesModerator: Aubrey Weigel9.05Dynamics of immunological tissue architecture in the human gutSimon Koplev9.25Reference-Free 3D Spatial Omics for Tissue InterpretationChenlei Gu9.45AI4CellFate: Interpretable Cell Fate Prediction in Microscopy Images with Machine LearningInês Cunha10.05Coffee and Poster session A11.45Session II: Next-Gen Model Organisms & TherapeuticsModerator: Patrick Bryant10.50AI-driven discovery of new Ribosome-Targeting Antimicrobial DrugsJoan Serrano Quilez11.10Infection as a physics problem: the case of schistosomiasis parasitesMelanie Hannebelle11.30Rationalising the effect of phospholipase D on lipid nanoparticles: from nanoscale to enzymatic activityMarco Fornasier 11.50Panel I: Space, Decisions, and No Boss: How do we allocate physical space and make difficult institutional decisions without a centralized hierarchy? 12.25Lunch and Poster session B13.15Session III: Planetary Biology & Environmental MetagenomicsModerator: TBD13.20Understanding symbiotic architectures: lichen symbiosis through the omics lensGulnara Tagirdzhanova13.40Towards an atlas of eukaryotic diversity in Swedish spruce forestsMahwash Jamy14.00Microbial meta-omics of the Baltic SeaEmma Bell14.20Coffee and Poster session C15.00Session IV: Chromosome Biology & Cellular Dynamics in DiseaseModerator: Abishek Arora15.05Repair without sisters: Linking 3D chromosome biology to DNA repairSunil Kumar15.25Investigating the mechanistic and functional role of focal lipid scrambling in immune cell signalingShambhavi Pandey15.45Chromosome Biology & Cellular Dynamics in DiseaseAnna Carbery16.05Panel II: Finding Your Family in the SciLifeLab Crowd: How do we create real environments for cross-disciplinary exchange?16.40Concluding remarks

Scientific committee

Hjalmar Brismar

Erik Benson

Magda Bienko

Anniina Vihervaara

Patrick Bryant

Gisele Miranda

Abishek Arora

Bruno Stojcic

Disa Larsson Hammarlöf, OO-support

Isolde Palombo, OO-support

Research Data Management in Life Science - Linköping
2026-09-21 10:00 - 17:00
Location: Rönnen – Campus University Hospital – Linköping University. On-site event arranged by SciLifeLab Linköping

Register here

Note: It is important to bring a laptop to actively participate in the workshops.

Discover how to effectively manage, share, and safeguard your research data through practical guidance from both local and national experts. Engage in discussions on best practices grounded in the FAIR principles and Open Science.

SciLifeLab Data Centre, National Bioinformatics Infrastructure Sweden (NBIS) and the LiU legal office welcome all life-science researchers and infrastructure experts in Linköping to join this event where we explore support for research data handling, GDPR and data management practices according to Findable, Accessible, Interoperable and Reusable (FAIR) principles and Open Science.

We specifically invite SciLifeLab Group leaders, Fellows and WCMM Fellows, and all PhD´s and PostDocs in their research groups to join this interactive event.

This event is informal and inclusive, so feel welcome to join and participate in our interesting discussions!

PROGRAM

Note: It is important to bring a laptop to actively participate in the workshops.

10.00-10.15: Welcome coffee/tea
Everyone is welcome for the coffee/tea. You can just walk in between 10.00-10.15.

10.15-10.30: Introduction
Introduction of the program.

10:30-12:00: Writing a strong Data Management Plan (DMP) – Improving the lifecycle of your research data
Managing research data involves a complex web of decisions. How do you ensure nothing falls through the cracks and that your data remains FAIR? The answer is a Data Management Plan (DMP).

This hands-on workshop emphasises data management planning at all project phases to keep your data secure and organised. Participants will gain direct access to the Data Stewardship Wizard (DSW) tool to begin drafting a customised DMP tailored to life science research projects.

Related content

12.00-13.00: Lunch break
Lunch is not included in this event. At Linköping University and the surrounding campus you will find several options for lunch.

13.00-14.30: Handling personal data in Life Science – Navigating GDPR and Swedish legislation
Are you confident in how your research project documents and processes personal data? This seminar guides you through the legal landscape, from the GDPR to specific Swedish national laws. Using a practical research scenario, we will clarify essential roles and terms, including:

Research principal (forskningshuvudman): Understanding the role and responsibilities of the organisation hosting the research.

Data controllers vs. processors: Identifying who is responsible for each stage of data processing.

Sensitive data: Best practices for securely sharing biomedical research data in FEGA Sweden while remaining compliant.

14.30-15.15: Marketplace: an interactive exhibition – including fika
Visit the Interactive Marketplace to explore local and national research data management services in an engaging and informal setting. Meet experts, discover practical support and tools, join interactive discussions, and learn how different services can support your research.Interested in contributing to the Marketplace and showcasing your data management support services? Please contact josefine.sandstrom@liu.se.

15.15-17.00: Open source software for research – Sharing code the right way
Research depends on software, but without open and FAIR practices, software can be difficult to understand, reproduce, and reuse. Open-source software means code that is not only available, but also licensed for free use, modification, and sharing. This workshop provides an overview of open science and FAIR software practices, and introduces a practical checklist for open and FAIR research software. Participants will apply these principles in a hands-on tutorial to improve the openness, transparency, and reusability of their research code.

17.00: End of the event
The event will end at 17.00. Thank you all for participating.

More information on Research Data Management and Open Science

Research Data Management (RDM) concerns the organization, storage, preservation, and sharing of data that is collected and analyzed during a research project. Proper planning and management of research data will make project management easier and more efficient while projects are being performed. It also facilitates sharing and allows others to validate as well as reuse the data.

Open Science is a set of principles and practices that aim to make scientific research from all fields accessible to everyone for the benefits of scientists and society as a whole. Open science is about making sure not only that scientific knowledge is accessible but also that the production of that knowledge itself is inclusive, equitable and sustainable.

Contact information: NBIS, SciLifeLab Data Centre – Data Management, and SciLifeLab Linköping. For questions, please contact josefine.sandstrom@liu.se

AI Frontiers in Life Sciences: From Models to Meaning
2026-10-02 08:00 - 17:00 | Humanistiska teatern, Uppsala, Thunbergsvägen 3C, Uppsala, 75238, Sweden
Image by Andreas Bergfeldt

Date and time: October 2, 2026 at 8.00-17.00 CET

Location: Humanistiska teatern – Uppsala, onsite and livestream via Zoom

The AI Frontiers in Life Sciences: From Models to Meaning symposium will bring together experts in artificial intelligence (AI) and life sciences to explore emerging directions, challenges, and opportunities for AI in life science research.

The symposium will feature presentations, demonstrations, and panel discussions with leading international and Swedish experts. The event is intended for researchers, infrastructure experts, and professionals interested in AI-driven life science research. Discussions will also provide input to the continued development of the SciLifeLab AI Strategy and ongoing and planned activities across SciLifeLab.

Further details, including the full programme, will be announced soon.

Registration:

In-person places are limited. If the in-person registration is full, you are welcome to join the waiting list or join the Zoom livestream of the event.

Register Here

Speakers:

Anna Kreshuk, EMBL
Interim Head of Cell Biology and Biophysics Unit

Anna Kreshuk is a Group Leader and Senior Scientist at the European Molecular Biology Laboratory (EMBL) in Heidelberg, where she develops computer vision methods for the analysis of microscopy images. She contributes to open-source tools including ilastik and PlantSeg and is an ELLIS Scholar and scientific co-coordinator of the Horizon Europe project AI4Life. She has served as Interim Head of EMBL’s Cell Biology and Biophysics Unit since 2024.

Web: Kreshuk Group

Florian Jug, Human Technopole
Head of Computational Biology Research Centre – Multimodal AI Across Scales, Computational biology, Research Group Leader,

Dr. Florian Jug holds a PhD in Computational Neuroscience from the Institute of Theoretical Computer Science at ETH Zurich. His research aims at pushing the boundary of what AI and machine learning can do to better analyze and quantify biological data. At HT, Dr. Jug covers the full breadth of bio-image computing, from research on novel methods for computer vision and machine learning, all the way to offering bio-image analysis as a service.

Web: Jug Group

Kadi Liis Saar, Recursion
Scientific Leader and Associate Principal Scientist, Recursion, a company focused on AI-driven solutions in drug discovery.

Dr. Kadi Liis Saar is the Scientific Leader and Associate Principal Scientist, Computational Biology & Data Science at Recursion, and elected member of Estonian Young Academy of Science. Dr. Saar is an interdisciplinary scientist and inventor with a background in chemical engineering and biotechnology (BA & MEng) and biophysical chemistry (PhD University of Cambridge 2018). Previously at Transition Bio, she was a Junior Research Fellow at St. John’s College, University of Cambridge and a Schmidt Science Fellow working between the Centre for Misfolding Diseases and the Maxwell Centre 2018-2022.

Web: Recursion

Samuel Kaski, ELLIS Institute Finland
Founding Director, ELLIS Institute Finland

Samuel Kaski is the founding director of ELLIS Institute Finland and leads the Finnish Center for Artificial Intelligence (FCAI). He is Professor of Machine Learning at Aalto University and Professor of Artificial Intelligence at the University of Manchester. His research focuses on probabilistic machine learning and collaborative AI, with applications in health, medicine and biology.

Web: Kaski Lab

Sebastian Lobentanzer, Helmholtz Center Munich
Principal Investigator, Computational Health Center

Sebastian Lobentanzer is a PI at the Computational Health Center at Helmholtz Center Munich since 2025, and in affiliation with the Open Targets group at the European Bioinformatics Institute (EMBL-EBI) since 2024. Sebastian serves as the head of computational biology at the German Center for Diabetes Research. He is the author of BioCypher – https://biocypher.org/ , BioChatter – https://biochatter.org/ projects.

Web: Lobentanzer Lab

Organisers: SciLifeLab Data Centre datacentre@scilifelab.se

WASP-HS & DDLS: Interdisciplinary Workshop
2026-10-12 12:00 - 2026-10-14 12:00 | Sigtunastiftelsen, Manfred Björkquists allé 4, Sigtuna, 193 31, Sweden
WASP-HS & DDLS: Joint Workshop at Sigtunastiftelsen, 12–14 October

This interdisciplinary workshop brings together a carefully selected group of 25 researchers from diverse fields to exchange perspectives on the ethical, legal, and social dimensions of data-intensive research in the life sciences. The conversation is not limited to lawyers and ethicists, but also includes researchers whose work both shapes and is shaped by these governance frameworks.

The aim is to bring together diverse expertise to explore key challenges, frame shared research questions, and spark new interdisciplinary collaborations.

Workshop Focus

→ Analyze governance structures and how they shape data-intensive research in precision medicine, epidemiology, infection biology, biodiversity, and molecular life sciences→ Identify key legal, regulatory, and ethical challenges in data-driven life sciences, with particular attention to the experiences of scientists working with these issues in practice→ Promote meaningful dialogue across disciplines→ Develop new interdisciplinary research initiatives

Duration

12 OctoberArrival and opening from lunch onwards

13 OctoberFull day of sessions

14 OctoberClosing and departure ending with lunch

Expression of Interest

Apply by May 14 to secure your spot. This workshop is open to researchers from both the WASP-HS and DDLS communities. Spots are limited to 25 participants, so make sure to fill in the Expression of Interest form to get a chance to attend.

Apply here

Organizers

Lianne Colonna,WASP-HS, Stockholm UniversityYana Litins’ka, WASP-HS, Lund UniversityHeidi Howard, DDLS, Chalmers University of TechnologyFrancis Lee, WASP-HS, Södertörn UniversityUlrika Wallenquist, DDLS, Uppsala UniversityBodil Formark,WASP-HS, Södertörn University
